112 related articles for article (PubMed ID: 28963677)
1. HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.
Xu H; Miao ZF; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Zhang JY; Liu XY; Wu JH; Xu HM
Virchows Arch; 2017 Dec; 471(6):743-751. PubMed ID: 28963677
[TBL] [Abstract][Full Text] [Related]
2. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
3. HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer.
Sun L; Lü J; Ding S; Bi D; Ding K; Niu Z; Liu P
Biomed Pharmacother; 2017 Jul; 91():202-207. PubMed ID: 28458158
[TBL] [Abstract][Full Text] [Related]
4. HCRP1 is downregulated in non-small cell lung cancer and regulates proliferation, invasion, and drug resistance.
Du Y; Wang P; Sun H; Yang J; Lang X; Wang Z; Zang S; Chen L; Ma J; Sun D
Tumour Biol; 2016 Oct; ():. PubMed ID: 27739029
[TBL] [Abstract][Full Text] [Related]
5. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of HCRP1 inhibits proliferation and invasion in glioma cells via suppressing the ERK and AKT signaling pathways.
Xu CY; Li ZJ; Hu WZ
Biomed Pharmacother; 2017 Nov; 95():31-36. PubMed ID: 28826094
[TBL] [Abstract][Full Text] [Related]
7. Decreased HCRP1 promotes breast cancer metastasis by enhancing EGFR phosphorylation.
Yang W; Wang JG; Wang Q; Qin Y; Lin X; Zhou D; Ren K; Hou C; Xu J; Liu X
Biochem Biophys Res Commun; 2016 Aug; 477(2):222-8. PubMed ID: 27311861
[TBL] [Abstract][Full Text] [Related]
8. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
9. NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer.
Jiang X; Jiang X; Yang Z
Gene; 2018 Aug; 668():114-120. PubMed ID: 29778424
[TBL] [Abstract][Full Text] [Related]
10. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
[TBL] [Abstract][Full Text] [Related]
11. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
Dong Q; Fu L; Zhao Y; Tan S; Wang E
Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.
Miao ZF; Wang ZN; Zhao TT; Xu YY; Wu JH; Liu XY; Xu H; You Y; Xu HM
Virchows Arch; 2015 Nov; 467(5):525-33. PubMed ID: 26293216
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients.
Liang M; Shi B; Liu J; He L; Yi G; Zhou L; Yu G; Zhou X
Drug Des Devel Ther; 2015; 9():3607-16. PubMed ID: 26213461
[TBL] [Abstract][Full Text] [Related]
14. TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance.
Miao ZF; Wang ZN; Zhao TT; Xu YY; Wu JH; Liu XY; Xu H; You Y; Xu HM
Virchows Arch; 2015 May; 466(5):525-32. PubMed ID: 25724180
[TBL] [Abstract][Full Text] [Related]
15. HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer.
Perisanidis C; Savarese-Brenner B; Würger T; Wrba F; Huynh A; Schopper C; Kornek G; Selzer E; Ewers R; Psyrri A; Krainer M; Filipits M
Oral Dis; 2013 Mar; 19(2):206-11. PubMed ID: 22891969
[TBL] [Abstract][Full Text] [Related]
16. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
[TBL] [Abstract][Full Text] [Related]
17. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of EGFR inhibits growth and invasion of gastric cancer cells.
Zhen Y; Guanghui L; Xiefu Z
Cancer Gene Ther; 2014 Nov; 21(11):491-7. PubMed ID: 25394504
[TBL] [Abstract][Full Text] [Related]
19. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
20. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
Lu T; Sun L; Zhu X
Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
